* Avanos Medical Inc AVNS.N AVNS.K is expected to show a
fall
in quarterly revenue when it reports results on November 1.
* The Alpharetta Georgia-based company is expected to
report a
16.1% decrease in revenue to $169.6 million from $202.1 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Avanos Medical Inc
is for
earnings of 28 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Avanos
Medical
Inc is $28, above its last closing price of $17.81.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.28 0.30 0.37 Beat 24.2
Mar. 31 2023 0.27 0.27 0.27 Met -1.5
Dec. 31 2022 0.49 0.49 0.60 Beat 22.4
Sep. 30 2022 0.35 0.35 0.38 Beat 7.8
Jun. 0.38 0.38 0.41 Beat 7.3
30 2022
Mar. 31 2022 0.26 0.26 0.26 Met 0
Dec. 31 2021 0.40 0.40 0.46 Beat 14.4
Sep. 30 2021 0.29 0.30 0.25 Missed -17.1
This summary was machine generated October 30 at 14:23 GMT. All
figures in US dollars unless otherwise stated